Page last updated: 2024-08-16

salmeterol xinafoate and Stroke

salmeterol xinafoate has been researched along with Stroke in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chao, HC; Chen, CY; Huang, YB; Lin, PC; Tsai, MJ; Tsai, YH; Yang, CJ1
Douglas, I; Grosso, A; Hingorani, AD; Hubbard, R; MacAllister, R; Smeeth, L1

Other Studies

2 other study(ies) available for salmeterol xinafoate and Stroke

ArticleYear
Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population.
    Medicine, 2015, Volume: 94, Issue:51

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Bronchodilator Agents; Budesonide, Formoterol Fumarate Drug Combination; Cardiovascular Diseases; Cholinergic Antagonists; Cohort Studies; Delayed-Action Preparations; Drug Combinations; Female; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Stroke; Taiwan; Tiotropium Bromide

2015
Inhaled tiotropium bromide and risk of stroke.
    British journal of clinical pharmacology, 2009, Volume: 68, Issue:5

    Topics: Administration, Inhalation; Aged; Albuterol; Androstadienes; Bronchodilator Agents; Cholinergic Antagonists; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluticasone; Humans; Ipratropium; Male; Middle Aged; Risk Factors; Salmeterol Xinafoate; Scopolamine Derivatives; Stroke; Tiotropium Bromide; United Kingdom

2009